Form D Explorer
Aevum Longevity Corp. · CIK 2076042

Report a data issueCitable research briefCompare issuerPrivate research collection

Aevum Longevity Corp.

CIK 2076042 · Corporation · Inc. BRITISH COLUMBIA, CANADA · VANCOUVER, British Columbia, Canada · Pharmaceuticals

These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.

Filings
1
Original notices
1
Amendments
0
Activity
Jul 9, 2025
through Jul 9, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot: how to read these fields

Form D · Jul 9, 2025

Reported offering amount
$2,251
Reported exemptions
Rule 506(b)
Reported amount sold
$2,251

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Related person name and locality match

Matches in stored disclosures are research leads. They do not establish common ownership or confirm identity.

Form D filings (1)